For the quarter ending 2026-03-31, TEM made $348,116K in revenue. -$125,919K in net income. Net profit margin of -36.17%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total net revenue | 348,116 | 367,211 | 334,206 | 314,635 |
| Cost of revenues-Genomic | - | - | 98,643 | 99,756 |
| Cost of revenues-Diagnostics | 100,960 | 107,551* | - | - |
| Cost of revenues-Data And Services | - | - | 25,621 | 19,840 |
| Cost of revenues-Data And Applications | 25,115 | 21,948* | - | - |
| Technology research and development | 45,921 | 40,147 | 38,087 | 34,482 |
| Research and development | 48,237 | 50,471 | 44,960 | 41,619 |
| Selling, general and administrative | 212,594 | 208,508 | 187,891 | 180,712 |
| Total cost and operating expenses | 432,827 | 428,624 | 395,202 | 376,409 |
| Loss from operations | -84,711 | -61,413 | -60,996 | -61,774 |
| Interest income | 3,866 | 5,122 | 4,600 | 1,093 |
| Interest expense | 14,341 | 15,286 | 15,399 | 21,579 |
| Gain on debt extinguishment | - | 0 | -12,034 | - |
| Other expense, net | -27,709 | 14,568 | 2,605 | 41,729 |
| Loss before benefit from income taxes | -122,895 | -57,009 | -81,224 | -40,531 |
| Benefit from income taxes | -62 | -5,992 | 276 | 212 |
| Losses from equity method investments | -3,086 | -3,149 | 1,518 | -2,100 |
| Net loss | -125,919 | -54,166 | -79,982 | -42,843 |
| Accretion of convertible preferred stock to redemption value | - | 0 | - | - |
| Dividends on series a, b,b-1,b-2,c, d, e, f, g,g-3,andg-4preferred shares | - | 0 | 0 | 0 |
| Cumulative undeclared dividends on series c preferred shares | - | 0 | 0 | 0 |
| Net loss attributable to common shareholders, basic | - | -54,166 | -79,982 | -42,843 |
| Basic EPS | -0.7 | -303.921 | -0.46 | -0.25 |
| Diluted EPS | -0.71 | -303.921 | -0.46 | -0.25 |
| Basic Average Shares | 178,880 | 178,224 | 174,945 | 173,381 |
| Diluted Average Shares | 178,964 | 178,224 | 174,945 | 173,381 |
Tempus AI, Inc. (TEM)
Tempus AI, Inc. (TEM)